Skip to main content
Top
Published in: Comparative Clinical Pathology 6/2019

01-12-2019 | Metastasis | Brief Communication

Clinical management of cutaneous hemangiosarcoma in canines: a review of five cases

Authors: Khan Sharun, Mohammed Arif Basha, Mudasir Ahmad Shah, K. Kumar, Pawan Kumar, S. Shivaraju, A. M. Pawde, Amarpal

Published in: Comparative Clinical Pathology | Issue 6/2019

Login to get access

Abstract

Hemangiosarcoma is a type of malignant vascular tumour that commonly affects the canines and has a very poor prognosis. Five dogs affected with cutaneous hemangiosarcoma were presented to Referral Veterinary Polyclinic, Indian Veterinary Research Institute, Izatnagar, over a 6-month period. All of the cases were subjected to thoracic radiography and intra-abdominal ultrasonography to rule out metastasis. The tumour mass was surgically excised in all the five animals. The cases were diagnosed as hemangiosarcoma on the basis of histopathology and immunohistochemistry. Two of the animals received chemotherapy using either vincristine or doxorubicin after surgical excision. The post-operative survival period was found to be slightly higher in the cases that received combined surgical excision and chemotherapy. The main aim of managing such cases should be to prolong the life of the animal by combining various treatment modalities like surgical excision, chemotherapy, immunotherapy and radiation therapy. This paper concludes that the combined use of surgical excision and chemotherapy can be superior to surgical excision alone in prolonging the life of dogs suffering from a cutaneous form of hemangiosarcoma.
Literature
go back to reference Batschinski K, Nobre A, Vargas-Mendez E, Tedardi MV, Cirillo J, Cestari G, Dagli MLZ (2018) Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014). Can Vet J 59(9):967–972PubMedPubMedCentral Batschinski K, Nobre A, Vargas-Mendez E, Tedardi MV, Cirillo J, Cestari G, Dagli MLZ (2018) Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014). Can Vet J 59(9):967–972PubMedPubMedCentral
go back to reference Bravo R, Frank R, Blundell PA, Macdonald-Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326:515–517CrossRef Bravo R, Frank R, Blundell PA, Macdonald-Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326:515–517CrossRef
go back to reference Brown NO, Patnaik AK, MacEwen EG (1985) Canine hemangiosarcoma: retrospective analysis of 104 cases. J Am Vet Med Assoc 186(1):56–58PubMed Brown NO, Patnaik AK, MacEwen EG (1985) Canine hemangiosarcoma: retrospective analysis of 104 cases. J Am Vet Med Assoc 186(1):56–58PubMed
go back to reference Clifford CA, Mackin AJ, Henry CJ (2000) Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med 14(5):479–485CrossRef Clifford CA, Mackin AJ, Henry CJ (2000) Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med 14(5):479–485CrossRef
go back to reference Dervisis NG, Dominguez PA, Newman RG, Cadile CD, Kitchell BE (2011) Treatment with DAV for advanced-stage hemangiosarcoma in dogs. J Am Anim Hosp Assoc 47(3):170–178CrossRef Dervisis NG, Dominguez PA, Newman RG, Cadile CD, Kitchell BE (2011) Treatment with DAV for advanced-stage hemangiosarcoma in dogs. J Am Anim Hosp Assoc 47(3):170–178CrossRef
go back to reference Fosmire SP, Dickerson EB, Scott AM, Bianco SR, Pettengill MJ, Meylemans H, Padilla M, Frazer-Abel AA, Akhtar N, Getzy DM, Wojcieszyn J (2004) Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab Investig 84(5):562–572CrossRef Fosmire SP, Dickerson EB, Scott AM, Bianco SR, Pettengill MJ, Meylemans H, Padilla M, Frazer-Abel AA, Akhtar N, Getzy DM, Wojcieszyn J (2004) Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab Investig 84(5):562–572CrossRef
go back to reference Gorden BH, Kim JH, Sarver AL, Frantz AM, Breen M, Lindblad-Toh K, O’Brien TD, Sharkey LC, Modiano JF, Dickerson EB (2014) Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. Am J Pathol 184(4):985–995CrossRef Gorden BH, Kim JH, Sarver AL, Frantz AM, Breen M, Lindblad-Toh K, O’Brien TD, Sharkey LC, Modiano JF, Dickerson EB (2014) Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. Am J Pathol 184(4):985–995CrossRef
go back to reference Karabağli G, Düzgün O, Yildar E, Erdoğan Ö, Gürel A (2011) A hemangiosarcoma case in a dog. İstanbul Üniversitesi Veteriner Fakültesi Dergisi 37(2):161–165 Karabağli G, Düzgün O, Yildar E, Erdoğan Ö, Gürel A (2011) A hemangiosarcoma case in a dog. İstanbul Üniversitesi Veteriner Fakültesi Dergisi 37(2):161–165
go back to reference Kim JH, Graef A, Dickerson E, Modiano J (2015) Pathobiology of hemangiosarcoma in dogs: research advances and future perspectives. Vet Sci 2(4):388–405CrossRef Kim JH, Graef A, Dickerson E, Modiano J (2015) Pathobiology of hemangiosarcoma in dogs: research advances and future perspectives. Vet Sci 2(4):388–405CrossRef
go back to reference Lamerato-Kozicki AR, Helm KM, Jubala CM, Cutter GC, Modiano JF (2006) Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Exp Hematol 34(7):870–878CrossRef Lamerato-Kozicki AR, Helm KM, Jubala CM, Cutter GC, Modiano JF (2006) Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Exp Hematol 34(7):870–878CrossRef
go back to reference Nóbrega DF, Sehaber VF, Madureira R, Bracarense APFRL (2019) Canine cutaneous haemangiosarcoma: biomarkers and survival. J Comp Pathol 166:87–96CrossRef Nóbrega DF, Sehaber VF, Madureira R, Bracarense APFRL (2019) Canine cutaneous haemangiosarcoma: biomarkers and survival. J Comp Pathol 166:87–96CrossRef
go back to reference Ogilvie GK, Powers BE, Mallinckrodt CH, Withrow SJ (1996) Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 10(6):379–384CrossRef Ogilvie GK, Powers BE, Mallinckrodt CH, Withrow SJ (1996) Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 10(6):379–384CrossRef
go back to reference Schultheiss PC (2004) A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Investig 16(6):522–526CrossRef Schultheiss PC (2004) A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Investig 16(6):522–526CrossRef
go back to reference Smetana K, Gyorkey F, Chan PK, Tan E, Busch H (1983) Proliferating cell nuclear antigen (PCNA) and human malignant tumor nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies. Blut 46(3):133–141CrossRef Smetana K, Gyorkey F, Chan PK, Tan E, Busch H (1983) Proliferating cell nuclear antigen (PCNA) and human malignant tumor nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies. Blut 46(3):133–141CrossRef
go back to reference U’ren LW, Biller BJ, Elmslie RE, Thamm DH, Dow SW (2007) Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma. J Vet Intern Med 21(1):113–120CrossRef U’ren LW, Biller BJ, Elmslie RE, Thamm DH, Dow SW (2007) Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma. J Vet Intern Med 21(1):113–120CrossRef
go back to reference Ward H, Fox LE, Calderwood-Mays MB, Hammer AS, Couto CG (1994) Cutaneous hemangiosarcoma in 25 dogs: a retrospective study. J Vet Intern Med 8(5):345–348CrossRef Ward H, Fox LE, Calderwood-Mays MB, Hammer AS, Couto CG (1994) Cutaneous hemangiosarcoma in 25 dogs: a retrospective study. J Vet Intern Med 8(5):345–348CrossRef
go back to reference Weisse C, Soares N, Beal MW, Steffey MA, Drobatz KJ, Henry CJ (2005) Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy: 23 cases (1986–2000). J Am Vet Med Assoc 226(4):575–579CrossRef Weisse C, Soares N, Beal MW, Steffey MA, Drobatz KJ, Henry CJ (2005) Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy: 23 cases (1986–2000). J Am Vet Med Assoc 226(4):575–579CrossRef
go back to reference Wendelburg KM, Price LL, Burgess KE, Lyons JA, Lew FH, Berg J (2015) Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001–2012). J Am Vet Med Assoc 247(4):393–403CrossRef Wendelburg KM, Price LL, Burgess KE, Lyons JA, Lew FH, Berg J (2015) Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001–2012). J Am Vet Med Assoc 247(4):393–403CrossRef
go back to reference Wiley JL, Rook KA, Clifford CA, Gregor TP, Sorenmo KU (2010) Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma. Vet Comp Oncol 8(3):221–233PubMed Wiley JL, Rook KA, Clifford CA, Gregor TP, Sorenmo KU (2010) Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma. Vet Comp Oncol 8(3):221–233PubMed
Metadata
Title
Clinical management of cutaneous hemangiosarcoma in canines: a review of five cases
Authors
Khan Sharun
Mohammed Arif Basha
Mudasir Ahmad Shah
K. Kumar
Pawan Kumar
S. Shivaraju
A. M. Pawde
Amarpal
Publication date
01-12-2019
Publisher
Springer London
Published in
Comparative Clinical Pathology / Issue 6/2019
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-019-03039-1

Other articles of this Issue 6/2019

Comparative Clinical Pathology 6/2019 Go to the issue